You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 14, 2024

Litigation Details for Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)

✉ Email this page to a colleague

« Back to Dashboard

Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)

Docket	⤷ Sign Up	Date Filed	2017-12-20
Court	District Court, S.D. New York	Date Terminated	2020-08-21
Cause	28:2201dj Declaratory Judgment	Assigned To	Colleen McMahon
Jury Demand	None	Referred To	Stewart D. Aaron
Parties	FERRING PHARMACEUTICALS INC.
Patents	7,405,203; 7,560,429; 7,579,321; 7,799,761; 7,947,654; 8,802,624; 9,220,747; 9,504,647; 9,539,302
Attorneys	Christopher J. Harnett
Firms	Jones Day (NYC)
Link to Docket	External link to docket

Small Molecule Drugs cited in Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC

The small molecule drugs covered by the patents cited in this case are ⤷ Sign Up and ⤷ Sign Up .

Details for Ferring Pharmaceuticals Inc. v. Serenity Pharmaceuticals, LLC (S.D.N.Y. 2017)

+ Get email alerts for changes to this table

Subscribe to access the full database, or Sign Up
Date Filed	Document No.	Description	Snippet	Link To Document
0000-00-00				External link to document
2017-04-28	1	Complaint	United States Patent No. 7,405,203, United States Patent No. 7,579,321, and United States Patent No. 7,799,761…Certificate, No. US 7,405,203 C1 (collectively, “the ’203 patent”). The ’203 patent bears the title, “…Application”), which matured into United States Patent No. 7,405,203, and U.S. Application No. 10/706,100 (“… issued United States Patent No. 7,579,321 (“the ’321 patent”). The ’321 patent bears the title, “Pharmaceutical… issued United States Patent No. 7,799,761 (“the ’761 patent”). The ’761 patent bears the title, “Pharmaceutical	External link to document
2018-06-28	101	Answer to Amended Complaint	, United States Patent No. 7,405,203 (the “’203 patent”); 7,579,321 (the “’321 patent”); and 7,799,761…United States Patent Nos. 7,405,203 (the “’203 patent”), and 7,579,321 (the “’321 patent”) (collectively… (INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 55. Counterclaimants incorporate…the ’203 patent on April 12, 2011 by issuing Ex Parte Reexamination Certificate No. US 7,405,203 C1. … (WILLFUL INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 70. Counterclaimants incorporate	External link to document
2018-07-19	115	Answer to Counterclaim	United States Patent Nos. 7,405,203 (“the ’203 patent”) and 7,579,321 (“the ’321 patent”). 9. … (INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 55. Ferring incorporates by… (WILLFUL INFRINGEMENT OF U.S. PATENT NO. 7,405,203) 70. Ferring incorporates by…Certificate No. US 7,405,203 C1 on April 12, 2011. Ferring states that the claims of the ’203 patent are invalid…issued Ex Parte Reexamination Certificate No. US 7,405,203 C1 on April 12, 2011. Ferring denies the remaining	External link to document
2017-06-09	12	Response/Reply - Miscellaneous	joint inventor of two patents assigned to Ferring -- U.S. Patent Nos. 7,560,429 and 7,947,654 (collectively…Defendants’ patents -- U.S. Patent Nos. 7,405,203; 7,579,321; and 7,799,761 (collectively, “the patents in suit…Fein’s three patents in suit. In that regard, Ferring contended that Dr. Fein’s patents included “significant…was the rightful owner of the three patents in suit; (2) those patents include “significant” and “inventive…the patents in suit, Ferring filed its DJ complaint in this Court asserting now that the patents in suit	External link to document
2018-09-19	201	Declaration	version of the original filed claims for U.S. Patent No. 7,405,203, # 2 Exhibit 18 - certified version of the… the original filed claims for U.S. Patent No. 7,579,321, # 3 Exhibit 19 - certified version of the Preliminary…December 2017 21 August 2020 1:17-cv-09922 Patent None District Court, S.D. New York	External link to document
>Date Filed	>Document No.	>Description	>Snippet	>Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.